Cannabinoid receptor type 2: a possible target in SARS-CoV-2 (CoV-19) infection?
F Rossi, C Tortora, M Argenziano, A Di Paola… - International Journal of …, 2020 - mdpi.com
In late December 2019, a novel coronavirus (SARS-CoV-2 or CoV-19) appeared in Wuhan,
China, causing a global pandemic. SARS-CoV-2 causes mild to severe respiratory tract …
China, causing a global pandemic. SARS-CoV-2 causes mild to severe respiratory tract …
Anti-inflammatory and antiviral effects of cannabinoids in inhibiting and preventing SARS-CoV-2 infection
M Janecki, M Graczyk, AA Lewandowska… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for
new options for both causal treatment and mitigation of its symptoms. Scientists and …
new options for both causal treatment and mitigation of its symptoms. Scientists and …
Use of cannabinoids to treat acute respiratory distress syndrome and cytokine storm associated with coronavirus disease-2019
P Nagarkatti, K Miranda, M Nagarkatti - Frontiers in Pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease caused by
the severe acute respiratory syndrome coronavirus 2. A significant proportion of COVID-19 …
the severe acute respiratory syndrome coronavirus 2. A significant proportion of COVID-19 …
CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV‐2 infections
MF Nagoor Meeran, C Sharma… - Drug Development …, 2021 - Wiley Online Library
The COVID‐19 pandemic caused by SARS‐CoV‐2 is a deadly disease afflicting millions.
The pandemic continues affecting population due to nonavailability of drugs and vaccines …
The pandemic continues affecting population due to nonavailability of drugs and vaccines …
β-Caryophyllene, a natural dietary CB2 receptor selective cannabinoid can be a candidate to target the trinity of infection, immunity, and inflammation in Covid-19
NK Jha, C Sharma, HM Hashiesh… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease (COVID-19), caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is an ongoing pandemic and presents a public health …
coronavirus 2 (SARS-CoV-2), is an ongoing pandemic and presents a public health …
In quest of a new therapeutic approach in COVID-19: the endocannabinoid system
O Lucaciu, O Aghiorghiesei, NB Petrescu… - Drug metabolism …, 2021 - Taylor & Francis
The SARS-Cov-2 virus caused a high morbidity and mortality rate disease, that is the COVID-
19 pandemic. Despite the unprecedented research interest in this field, the lack of specific …
19 pandemic. Despite the unprecedented research interest in this field, the lack of specific …
Δ9-tetrahydrocannabinol prevents mortality from acute respiratory distress syndrome through the induction of apoptosis in immune cells, leading to cytokine storm …
A Mohammed, H FK Alghetaa, K Miranda… - International Journal of …, 2020 - mdpi.com
Acute Respiratory Distress Syndrome (ARDS) causes up to 40% mortality in humans and is
difficult to treat. ARDS is also one of the major triggers of mortality associated with …
difficult to treat. ARDS is also one of the major triggers of mortality associated with …
Cannabis for COVID-19: can cannabinoids quell the cytokine storm?
ES Onaivi, V Sharma - Future science OA, 2020 - Taylor & Francis
The recent emergence of SARS coronavirus 2 (SARS-CoV-2) has resulted in the alarming
spread of the highly infectious and contagious COVID-19 pandemic that is causing …
spread of the highly infectious and contagious COVID-19 pandemic that is causing …
Effects of pro‐inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
L Jean‐Gilles, M Braitch, ML Latif, J Aram… - Acta …, 2015 - Wiley Online Library
Aims To investigate the regulation of cannabinoid receptors CB 1 and CB 2 on immune cells
by pro‐inflammatory cytokines and its potential relevance to the inflammatory neurological …
by pro‐inflammatory cytokines and its potential relevance to the inflammatory neurological …
Opportunities, challenges and pitfalls of using cannabidiol as an adjuvant drug in COVID-19
B Malinowska, M Baranowska-Kuczko… - International journal of …, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to
coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ …
coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ …